US Patent Issued to Orionis Biosciences, VIB VZW, Universiteit Gent on Dec. 16 for "Chimeric protein, and encoding nucleic acid thereof, comprising interferon-Beta and a targeting moiety comprising a single-domain antibody or single-chain antibody" (Belgian, American Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,436, issued on Dec. 16, was assigned to Orionis Biosciences BV (Zwijnaarde, Belgium), VIB VZW (Ghent, Belgium) and Universiteit Gent (Ghent, Belgium).

"Chimeric protein, and encoding nucleic acid thereof, comprising interferon-Beta and a targeting moiety comprising a single-domain antibody or single-chain antibody" was invented by Nikolai Kley (Newton, Mass.), Jan Tavernier (Balegem, Belgium) and Frank Peelman (Gentbrugge, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to chimeric proteins comprising mutant interferon-Beta and their use as therapeutic agents."

The patent was filed on Dec. 10, 2021, un...